Long-term effectiveness and safety of upadacitinib for Japanese patients with moderate-to-severe atopic dermatitis: a real-world clinical study
AbstractBackground Previous clinical trials presented efficacy and safety of Janus kinase 1 inhibitor upadacitinib through 52 weeks for moderate-to-severe atopic dermatitis (AD).Objectives To assess the effectiveness and safety of upadacitinib through 48 weeks in real-world clinical practice for Jap...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Formato: | Livro |
| Publicado em: |
Taylor & Francis Group,
2024-12-01T00:00:00Z.
|
| Assuntos: | |
| Acesso em linha: | Connect to this object online. |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
Internet
Connect to this object online.3rd Floor Main Library
| Número de Chamada: |
A1234.567 |
|---|---|
| Cópia 1 | Disponível |